Glaxosmithkline Pakistan LimitedPSX: GLAXO

Board Meeting Quarter 4, 2025

· Issued by Glaxosmithkline Pakistan Limited

Maich 18, 2026

The General Manager

Pakistan Stock Exchange Limited Stock Exchange Building

Stock Exchange Road Karachi - 74000

Dear Sir,

Subject: Board of Directors Meeting

GlaxoSmithKline Pakistan Limited 35-Dockyard Road, West Wharf, Karachi - 74000, Pakistan

T +92 21 111 475 725

Please be informed that a meeting of the Board of Directors of GlaxoSmitliKline Pakistan Limited, for consideration of Annual Accounts of the Company for the period ended December 31, 2025, will be held virtually from the head office at 35-Dockyard Road, West Wharf, Kaiachi on Maich 26"', 2026, at 11.30 am.

The Company has declared a closed period from March 19"', 2026, to March 26"', 2026, as required under the Corporate Governance Regulations and requirements of the Exchange as per clause 5.6.4 of the PSX regulations.

Accordingly, no director, CEO, or Executive shall directl; or indirectly, deal with the shares of the Company in any manner during the closed period. The employees of the Company have been communicated the closed period, as required.

You may please inform the TRE Certificate Holders of the Exchange accordingly.

Tliaiilcing you,

GlaxoSmithK,jine Pakistan Limited

Hina Mtr

Company Secretary

CC: Central Depository Company of Pakistan Limited CDC House. 99-B, Block B, S.M.C.H.S,

Main Sharah-e-Faisal, Karachi - 74000

Registered in Pakistan, registration no. K-304 of 1948-49



Earlier from Glaxosmithkline Pakistan

All Glaxosmithkline Pakistan news releases